# Phase I, Open Label, Single Center Safety Study of [F-18]FLT

> **NCT00553748** · PHASE1 · COMPLETED · sponsor: **Siemens Molecular Imaging** · enrollment: 11 (actual)

## Conditions studied

- Brain Cancer

## Interventions

- **DRUG:** F-18 FLT

## Key facts

- **NCT ID:** NCT00553748
- **Lead sponsor:** Siemens Molecular Imaging
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2008-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00553748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00553748, "Phase I, Open Label, Single Center Safety Study of [F-18]FLT". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00553748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*